Overview

An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus

Status:
Unknown status
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to to determine whether atorvastatin 40mg per day is effective in the treatment of SLE.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Buddhist Tzu Chi General Hospital
Collaborator:
Pfizer
Treatments:
Atorvastatin
Atorvastatin Calcium